Chemoinformaics analysis of phosphatidylethanolamine
| Molecular Weight | 299.216 | nRot | 9 |
| Heavy Atom Molecular Weight | 281.072 | nRig | 4 |
| Exact Molecular Weight | 299.077 | nRing | 0 |
| Solubility: LogS | 0.125 | nHRing | 0 |
| Solubility: LogP | -1.94 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 38.1783 |
| nHD | 2 | BPOL | 34.8757 |
| QED | 0.452 |
| Synth | 4.33 |
| Natural Product Likeliness | 0.998 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.006 |
| HIA | 0.342 |
| CACO-2 | -5.778 |
| MDCK | 0.000772 |
| BBB | 0.38 |
| PPB | 0.0962945 |
| VDSS | 0.625 |
| FU | 0.904121 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.058 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.05 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.086 |
| CYP2d6-inh | 0.087 |
| CYP2d6-sub | 0.149 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.114 |
| CL | 2.055 |
| T12 | 0.802 |
| hERG | 0.024 |
| Ames | 0.877 |
| ROA | 0.002 |
| SkinSen | 0.738 |
| Carcinogencity | 0.491 |
| EI | 0.104 |
| Respiratory | 0.11 |
| NR-Aromatase | 0.001 |
| Antiviral | No |
| Prediction | 0.733666 |